Skip to main content

Economic analysis of pegfilgrastim in patients receiving cancer chemotherapy.

Publication ,  Conference
Cosler, LE; Eldar-Lissai, A; Dale, DC; Crawford, J; Lyman, GH
Published in: JOURNAL OF CLINICAL ONCOLOGY
2005

Duke Scholars

Published In

JOURNAL OF CLINICAL ONCOLOGY

EISSN

1527-7755

ISSN

0732-183X

Publication Date

2005

Volume

23

Issue

16

Start / End Page

538S / 538S

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Cosler, L. E., Eldar-Lissai, A., Dale, D. C., Crawford, J., & Lyman, G. H. (2005). Economic analysis of pegfilgrastim in patients receiving cancer chemotherapy. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 23, pp. 538S-538S).
Cosler, L. E., A. Eldar-Lissai, D. C. Dale, J. Crawford, and G. H. Lyman. “Economic analysis of pegfilgrastim in patients receiving cancer chemotherapy.” In JOURNAL OF CLINICAL ONCOLOGY, 23:538S-538S, 2005.
Cosler LE, Eldar-Lissai A, Dale DC, Crawford J, Lyman GH. Economic analysis of pegfilgrastim in patients receiving cancer chemotherapy. In: JOURNAL OF CLINICAL ONCOLOGY. 2005. p. 538S-538S.
Cosler, L. E., et al. “Economic analysis of pegfilgrastim in patients receiving cancer chemotherapy.JOURNAL OF CLINICAL ONCOLOGY, vol. 23, no. 16, 2005, pp. 538S-538S.
Cosler LE, Eldar-Lissai A, Dale DC, Crawford J, Lyman GH. Economic analysis of pegfilgrastim in patients receiving cancer chemotherapy. JOURNAL OF CLINICAL ONCOLOGY. 2005. p. 538S-538S.

Published In

JOURNAL OF CLINICAL ONCOLOGY

EISSN

1527-7755

ISSN

0732-183X

Publication Date

2005

Volume

23

Issue

16

Start / End Page

538S / 538S

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences